The store will not work correctly when cookies are disabled.
9-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)nonanoic Acid
ID: ALA3086863
PubChem CID: 136241610
Max Phase: Preclinical
Molecular Formula: C15H22N4O3
Molecular Weight: 306.37
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc2[nH]c(CCCCCCCCC(=O)O)cc2c(=O)[nH]1
Standard InChI: InChI=1S/C15H22N4O3/c16-15-18-13-11(14(22)19-15)9-10(17-13)7-5-3-1-2-4-6-8-12(20)21/h9H,1-8H2,(H,20,21)(H4,16,17,18,19,22)
Standard InChI Key: SQEUPDXSHKECRJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
19.2273 -26.1460 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2262 -26.9655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9342 -27.3745 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9325 -25.7371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6411 -26.1424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6459 -26.9610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4259 -27.2094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.9033 -26.5443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4181 -25.8849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5182 -27.3735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9300 -24.9199 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.7204 -26.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1249 -25.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9420 -25.8246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3464 -25.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1636 -25.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5680 -24.3995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3852 -24.3947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7896 -23.6846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6068 -23.6798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0072 -22.9706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0155 -24.3860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
4 11 2 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.37 | Molecular Weight (Monoisotopic): 306.1692 | AlogP: 2.19 | #Rotatable Bonds: 9 |
Polar Surface Area: 124.86 | Molecular Species: ACID | HBA: 4 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.30 | CX Basic pKa: 4.61 | CX LogP: 1.72 | CX LogD: -0.09 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.53 | Np Likeness Score: 0.34 |
References
1. Wang Y, Cherian C, Orr S, Mitchell-Ryan S, Hou Z, Raghavan S, Matherly LH, Gangjee A.. (2013) Tumor-targeting with novel non-benzoyl 6-substituted straight chain pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis., 56 (21): [PMID:24111942] [10.1021/jm401139z] |